Catia Oliveira

The paper engineers high-affinity cross-reactive antibodies with minimal mutations using deep learning and deep mutational scanning.

This paper introduces OncoMimics, a peptide-based immunotherapy using molecular mimicry between commensal bacterial and tumor antigens to induce cross-reactive T cell responses, showing early clinical success in glioblastoma.